LEADER 04428nam 22006975 450 001 9910411944003321 005 20220602144930.0 010 $a3-030-45562-9 024 7 $a10.1007/978-3-030-45562-0 035 $a(CKB)4100000011343558 035 $a(DE-He213)978-3-030-45562-0 035 $a(MiAaPQ)EBC6268598 035 $a(PPN)269145354 035 $a(EXLCZ)994100000011343558 100 $a20200707d2020 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aSecondary Hypertension /$fedited by Alberto Morganti, Enrico Agabiti Rosei, Franco Mantero 205 $a1st ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (X, 209 p. 22 illus., 9 illus. in color.) 225 1 $aUpdates in Hypertension and Cardiovascular Protection,$x2366-4606 311 $a3-030-45561-0 327 $a1. Renal parenchimal disease -- 2. Atherosclerotic renovascular disease -- 3. Fibromuscular Dysplasia -- 4. Primary aldosteronism -- 5. Familial aldosteronism -- 6. Monogenic forms of hypertension. - 7. Pheochromocytoma - Paraganglioma -- 8. Cushing disease -- 9. Vascular disease -- 10. OSAS -- 11. Drug induced hypertension -- 12. Acromegaly -- 13. Organ damage in secondary hypertension. - 14. Hemodynamics and CV risk in secondary hypertension. 330 $aThis book offers an overview of the latest advances in the epidemiological, pathophysiological, diagnostic and therapeutic aspects of secondary hypertension, provided by a group of the most highly respected European experts in this field. It is common belief that secondary forms of hypertension are rare, although in 95% of patients the cause of high blood pressure is unknown ? euphemistically referred to as ?essential?. There is increasing evidence from epidemiological studies that the prevalence of secondary hypertension is much higher than previously thought, accounting for 20%-25% of all hypertensive patients. There are additional, very good reasons for identifying those patients with secondary hypertension: firstly, they are exposed to a greater risk of suffering major cardiovascular events than patients with essential hypertension who have the same blood pressure level, and for this reason require particular care. Secondly, these patients can be relieved of a lifetime of pharmacological therapy or, at least, have a chance to be treated with more specific and effective medications. A high degree of clinical skill is required to recognize the often vague and subtle symptoms and signs that characterize patients with secondary hypertension, and clinicians need to fully comprehend the mechanisms responsible for the development and maintenance of high blood pressure. Shedding new light on a complex area of cardiovascular medicine, the book enables readers to better treat affected patients. 410 0$aUpdates in Hypertension and Cardiovascular Protection,$x2366-4606 606 $aCardiology 606 $aNephrology 606 $aEndocrinology  606 $aNeurology  606 $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037 606 $aNephrology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33126 606 $aEndocrinology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33053 606 $aNeurology$3https://scigraph.springernature.com/ontologies/product-market-codes/H36001 606 $aHipertensió$2thub 606 $aCardiologia$2thub 608 $aLlibres electrònics$2thub 615 0$aCardiology. 615 0$aNephrology. 615 0$aEndocrinology . 615 0$aNeurology . 615 14$aCardiology. 615 24$aNephrology. 615 24$aEndocrinology. 615 24$aNeurology. 615 7$aHipertensió 615 7$aCardiologia 676 $a616.132 702 $aMorganti$b Alberto$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aAgabiti Rosei$b Enrico$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aMantero$b Franco$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910411944003321 996 $aSecondary Hypertension$91992466 997 $aUNINA